Patient Advocacy and Therapeutic Development for Huntington’s Disease
Time: 11am – 12pm EST
Date: August 11, 2022
Dan O’Reilly, PhD, a former OTS Trainee BoD member, focuses his research on developing siRNA therapeutics for Huntington’s Disease. Join us as Dr. O’Reilly discusses patient advocacy and Huntington’s Disease research.
Daniel O’Reilly, PhD
Post-Doctoral Associate at Khvorova Lab, RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA